July 2008- Volume 4, Issue 7
In this Issue
Automation & Instrumentation
Invitrogen, Applied Bio to merge
Invitrogen, Applied Bio to merge
Invitrogen ponies up $6.7 billion in cash and stock to create a life sciences juggernaut
A cultural connection
A cultural connection
Thermo Fisher reaches across all divisions to create the Cell Culture Excellence Program
Covering the sample prep bases
Covering the sample prep bases
Leica Microsystems acquires Bal-Tec to provide complete sample prep offering for microscopy
Genomics & Proteomics
Killer turned savior
Killer turned savior
Insights into Huntington’s protein lead to major discovery for vaccine adjuvants
U.S. provides personal touch
U.S. provides personal touch
TGen, PPM and ISB team up to help Luxembourg harness genomics and proteomics tech
Three\'s company
Three\'s company
1000 Genomes Project welcomes Illumina, Applied Bio and 454
Here we genome again
Here we genome again
The Human Microbiome Project, dubbed the ‘Second Human Genome Project,’ poses more complexities
Research & Development
Oh la la! Ipsen goes wild
Oh la la! Ipsen goes wild
French pharma expands global footprint with three U.S. deals totaling $450M
Wanted: CNS disorder drugs
Wanted: CNS disorder drugs
Roche, PsychoGenics team up to identify neuropsyciatric disorder treatments
Pink slips pile up
Pink slips pile up
GSK axes 350 R&D jobs
Locus furthers cancer focus
Locus furthers cancer focus
Locus inks cancer research deals with two academic centers
Upping the antibody ante
Upping the antibody ante
Novartis buys Protez in deal worth up to $400 million
Informatics
Putting teeth into bioinformatics
Putting teeth into bioinformatics
Waters, Rosetta extend proteomic research collaboration
Linguamatics joins Microsoft BioIT Alliance
Linguamatics joins Microsoft BioIT Alliance
Linguamatics Ltd., a provider of enterprise text mining for life science researchers, announced in June that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.
Attractive acquisition
Attractive acquisition
Parexel makes $182M offer for ClinPhone
One platform for MS research
One platform for MS research
MRF taps CDD’s Web-based software to integrate MS research efforts
Rise of Phenyx
Rise of Phenyx
GeneBio marries Phenyx platform with Nonlinear’s Progenesis MS software
Open biology
Open biology
NextBio expands search engine and launches free public access
Global News
Big pharma goes generic
Big pharma goes generic
Daiichi Sankyo to take control of Ranbaxy in $4.6 billion deal
Bidding for generic stake?
Bidding for generic stake?
Sanofi-aventis, PPF on verge of bidding war for Czech generic drug maker Zentiva
CytRx to acquire Innovive
CytRx to acquire Innovive
$23 million deal creates company focused on molecular chaperone technology platform, near-term oncology opportunities
Producing purified plasmid DNA
Producing purified plasmid DNA
Boehringer Ingelheim and GENEART to offer design and production services for DNA therapeutics, vaccines
Symphogen in infectious disease collaboration with Genentech
Symphogen in infectious disease collaboration with Genentech
Symphogen A/S announced it entered a global strategic collaboration with Genentech Inc. for antibody therapeutics against three undisclosed infectious disease targets.
Commentary
What’s new can be old in life sciences
What’s new can be old in life sciences
When you’ve been around the block a few times, you start to recognize familiar landmarks. When you are young, perspective is harder, but it’s not disabling, either.
Editor's Focus
A generic tale: Go east, young man!
A generic tale: Go east, young man!
With apologies to the 19th century New York Tribune editor, Horace Greeley, the phrase "go west, young man!" can now be turned around for life sciences and pharmaceutical companies looking for opportunity at the beginning of this millennium.
